미국 · 보도자료 · Belite Bio, Inc · 2026-10-01 12:00
주요 의학 학술대회 2곳서 구두 발표 진행 예정
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio ® ” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that its data will be presented at the Innovate Retina conference being held on October 8, 2026, in New Or
